C. Boulanger

Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma

N. Etienne-Selloum, L. Fornecker, F. Slimano, 2022, Journal of Cancer Research and Clinical Oncology.

Economical simulations for the optimal use of anti-programmed cell death-1 in advanced melanoma patients: Report of a budget impact analysis

F. Slimano, Justine Clarenne, L. Visseaux, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Safety and Survival Outcomes in Lung Cancer Patients Receiving Carboplatin: Impact of Uncapped Dosage

M. Dewolf, F. Slimano, C. Mongaret, 2021, Chemotherapy.

A UV-Raman spectrometry method for quality control of anticancer preparations: Results after 18 months of implementation in hospital pharmacy.

P. Collart-Dutilleul, G. Ubeaud‐Séquier, G. Becker, 2016, International journal of pharmaceutics.